These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 12073813)

  • 21. Suture prices unlikely to drop further.
    Hosp Mater Manage; 1998 Dec; 23(12):1, 14-5. PubMed ID: 10338811
    [No Abstract]   [Full Text] [Related]  

  • 22. Stats. 1994 prices? Don't expect much change.
    Mater Manag Health Care; 1994 May; 3(5):76. PubMed ID: 10133842
    [No Abstract]   [Full Text] [Related]  

  • 23. Price survey. Overall, i.v. solution prices edging up.
    Hosp Mater Manage; 1996 Nov; 21(11):1, 10-1. PubMed ID: 10162842
    [No Abstract]   [Full Text] [Related]  

  • 24. Resource markets nudge IV prices up, survey says.
    Hosp Mater Manage; 2005 Nov; 30(11):1, 11-13. PubMed ID: 16363490
    [No Abstract]   [Full Text] [Related]  

  • 25. Tax changes may hike equipment costs.
    Simler SL
    Mod Healthc; 1983 Jul; 13(7):26-7. PubMed ID: 10261130
    [No Abstract]   [Full Text] [Related]  

  • 26. Price survey. PTCA prices still moving down.
    Hosp Mater Manage; 2002 Jun; 27(6):1, 12-3. PubMed ID: 12073811
    [No Abstract]   [Full Text] [Related]  

  • 27. Needle and syringe prices up 6.6%.
    Hosp Mater Manage; 1995 Jan; 20(1):1, 12-3. PubMed ID: 10139321
    [No Abstract]   [Full Text] [Related]  

  • 28. Med-surg prices are predicted to be up only modestly in 1996.
    Hosp Mater Manage; 1996 Mar; 21(3):11. PubMed ID: 10156497
    [No Abstract]   [Full Text] [Related]  

  • 29. Capital equipment buy should be part of strategic plan.
    Burton GD
    Hosp Mater Manage; 1998 Jul; 23(7):12-3. PubMed ID: 10183021
    [No Abstract]   [Full Text] [Related]  

  • 30. Survey: equipment budgets up; use in outpatient areas growing.
    Anderson HJ
    Hospitals; 1992 Sep; 66(18):38, 40, 42-4. PubMed ID: 1516919
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Needle, syringe prices show net gain.
    Hosp Mater Manage; 1998 Mar; 23(3):1, 15-6. PubMed ID: 10178805
    [No Abstract]   [Full Text] [Related]  

  • 32. Inflation frustration. Higher prices for raw materials have begun to hit the cost of health products, and GPOs are feeling the pressure.
    Rhea S
    Mod Healthc; 2008 Sep; 38(35):S1-5. PubMed ID: 18792596
    [No Abstract]   [Full Text] [Related]  

  • 33. HSCA price forecast. Raw material costs will drive price hikes this year.
    Hosp Mater Manage; 2000 Feb; 25(2):12-4. PubMed ID: 11184609
    [No Abstract]   [Full Text] [Related]  

  • 34. Pacemaker prices decline, but gently.
    Hosp Mater Manage; 1998 Jul; 23(7):1, 19-21. PubMed ID: 10183018
    [No Abstract]   [Full Text] [Related]  

  • 35. Hospitals keep buying, but are more cautious about upcoming capital equipment purchases.
    Werner C
    Hosp Mater Manage; 1993 May; 18(5):9. PubMed ID: 10126216
    [No Abstract]   [Full Text] [Related]  

  • 36. Materials, labor to account for many price hikes.
    Hosp Mater Manage; 2002 Jul; 27(7):20-1. PubMed ID: 12134385
    [No Abstract]   [Full Text] [Related]  

  • 37. Med-surg chargeables show decline.
    Wyatt J
    Hosp Mater Manage; 1993 Dec; 18(12):9. PubMed ID: 10130621
    [No Abstract]   [Full Text] [Related]  

  • 38. Hospital supply and pharmaceutical costs are tied to competition in marketplace.
    Appel GL
    Hosp Mater Manage; 1995 Dec; 20(12):8-9. PubMed ID: 10152660
    [No Abstract]   [Full Text] [Related]  

  • 39. Stats. Capitalizing on expenditures.
    Hoppszallern S
    Mater Manag Health Care; 2002 Oct; 11(10):36. PubMed ID: 12412531
    [No Abstract]   [Full Text] [Related]  

  • 40. 15% spending growth projected.
    Wagner M
    Mod Healthc; 1991 Nov; 21(45):22. PubMed ID: 10114679
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.